Elizabeth Kovacs
Concepts (575)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Burns | 65 | 2026 | 374 | 18.400 |
Why?
| | Ethanol | 57 | 2026 | 631 | 9.100 |
Why?
| | Alcoholic Intoxication | 16 | 2025 | 76 | 6.130 |
Why?
| | Alcohol Drinking | 26 | 2025 | 837 | 4.610 |
Why?
| | Pneumonia | 14 | 2025 | 636 | 4.430 |
Why?
| | Aging | 28 | 2025 | 1969 | 3.750 |
Why?
| | Inflammation | 33 | 2025 | 2878 | 3.600 |
Why?
| | Gastrointestinal Microbiome | 11 | 2026 | 767 | 3.420 |
Why?
| | Alcoholism | 23 | 2025 | 822 | 2.940 |
Why?
| | Lung Transplantation | 15 | 2019 | 332 | 2.430 |
Why?
| | Immunity, Innate | 12 | 2017 | 835 | 2.380 |
Why?
| | Cytokines | 20 | 2025 | 2067 | 2.190 |
Why?
| | Interleukin-6 | 16 | 2025 | 776 | 2.160 |
Why?
| | Mice | 72 | 2026 | 18329 | 2.040 |
Why?
| | Mice, Inbred C57BL | 41 | 2026 | 5983 | 2.030 |
Why?
| | Liver Diseases | 6 | 2025 | 305 | 2.030 |
Why?
| | Feces | 4 | 2025 | 495 | 1.990 |
Why?
| | Macrophages, Alveolar | 9 | 2022 | 373 | 1.990 |
Why?
| | Lung | 25 | 2025 | 4106 | 1.990 |
Why?
| | Neutrophils | 16 | 2022 | 1124 | 1.950 |
Why?
| | Animals | 102 | 2026 | 38030 | 1.890 |
Why?
| | Dysbiosis | 5 | 2025 | 187 | 1.850 |
Why?
| | Burns, Inhalation | 5 | 2020 | 9 | 1.820 |
Why?
| | Intestines | 4 | 2022 | 354 | 1.800 |
Why?
| | Binge Drinking | 8 | 2023 | 45 | 1.740 |
Why?
| | Wound Healing | 11 | 2015 | 355 | 1.690 |
Why?
| | Macrophages | 13 | 2016 | 1507 | 1.620 |
Why?
| | Gastroesophageal Reflux | 10 | 2014 | 237 | 1.600 |
Why?
| | Glycerophospholipids | 6 | 2025 | 39 | 1.600 |
Why?
| | Bacterial Translocation | 8 | 2026 | 52 | 1.590 |
Why?
| | Bronchoalveolar Lavage Fluid | 15 | 2018 | 638 | 1.540 |
Why?
| | Lung Diseases | 9 | 2018 | 780 | 1.440 |
Why?
| | Age Factors | 17 | 2025 | 3342 | 1.440 |
Why?
| | Disease Models, Animal | 25 | 2025 | 4560 | 1.420 |
Why?
| | Intestinal Mucosa | 5 | 2025 | 675 | 1.320 |
Why?
| | Phagocytosis | 7 | 2016 | 296 | 1.310 |
Why?
| | Smoke Inhalation Injury | 6 | 2013 | 29 | 1.260 |
Why?
| | Neutrophil Infiltration | 8 | 2016 | 104 | 1.220 |
Why?
| | Biomarkers | 21 | 2025 | 4295 | 1.150 |
Why?
| | Respiratory Aspiration | 4 | 2013 | 32 | 1.140 |
Why?
| | Liver | 12 | 2025 | 1896 | 1.130 |
Why?
| | Public Opinion | 4 | 2023 | 62 | 1.120 |
Why?
| | Pancreatitis-Associated Proteins | 2 | 2025 | 12 | 1.110 |
Why?
| | Pseudomonas Infections | 4 | 2016 | 230 | 1.070 |
Why?
| | Central Nervous System Depressants | 3 | 2015 | 84 | 1.040 |
Why?
| | Macrophage Activation | 6 | 2019 | 181 | 1.040 |
Why?
| | Male | 86 | 2026 | 72842 | 1.030 |
Why?
| | Antimicrobial Cationic Peptides | 2 | 2025 | 81 | 1.010 |
Why?
| | Immune System | 5 | 2017 | 180 | 0.950 |
Why?
| | Bronchiolitis Obliterans | 6 | 2014 | 61 | 0.940 |
Why?
| | Colon | 2 | 2025 | 309 | 0.920 |
Why?
| | Calgranulin A | 1 | 2025 | 11 | 0.910 |
Why?
| | Postoperative Complications | 8 | 2025 | 2970 | 0.900 |
Why?
| | Radiation Injuries, Experimental | 3 | 2013 | 20 | 0.890 |
Why?
| | tau Proteins | 1 | 2025 | 105 | 0.860 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2025 | 79 | 0.860 |
Why?
| | Blood-Brain Barrier | 1 | 2026 | 160 | 0.850 |
Why?
| | Wound Infection | 2 | 2016 | 60 | 0.830 |
Why?
| | Pneumonia, Bacterial | 2 | 2016 | 113 | 0.830 |
Why?
| | Mice, Inbred BALB C | 12 | 2020 | 1261 | 0.780 |
Why?
| | Humans | 103 | 2025 | 145474 | 0.770 |
Why?
| | Central Nervous System | 1 | 2025 | 282 | 0.770 |
Why?
| | Cellular Senescence | 1 | 2025 | 226 | 0.770 |
Why?
| | Skin | 6 | 2016 | 753 | 0.770 |
Why?
| | Chemokines | 8 | 2023 | 217 | 0.740 |
Why?
| | Radiation Injuries | 2 | 2016 | 149 | 0.730 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2022 | 47 | 0.700 |
Why?
| | Biomedical Research | 4 | 2018 | 717 | 0.700 |
Why?
| | Delirium | 1 | 2023 | 105 | 0.680 |
Why?
| | Tight Junctions | 1 | 2021 | 82 | 0.670 |
Why?
| | Signal Transduction | 14 | 2022 | 5216 | 0.670 |
Why?
| | Pneumococcal Infections | 1 | 2022 | 103 | 0.670 |
Why?
| | Female | 64 | 2025 | 78844 | 0.660 |
Why?
| | Immunity, Cellular | 5 | 2018 | 274 | 0.660 |
Why?
| | Astrocytes | 1 | 2022 | 228 | 0.640 |
Why?
| | Pore Forming Cytotoxic Proteins | 1 | 2020 | 15 | 0.620 |
Why?
| | Leukocytes | 3 | 2011 | 296 | 0.620 |
Why?
| | Estrogens | 2 | 2016 | 367 | 0.610 |
Why?
| | Wounds and Injuries | 4 | 2015 | 961 | 0.600 |
Why?
| | Allergy and Immunology | 2 | 2017 | 43 | 0.590 |
Why?
| | von Willebrand Factor | 1 | 2019 | 85 | 0.590 |
Why?
| | Hepatitis, Alcoholic | 1 | 2018 | 16 | 0.560 |
Why?
| | Gastrointestinal Tract | 2 | 2020 | 204 | 0.560 |
Why?
| | Tumor Necrosis Factor-alpha | 6 | 2022 | 1217 | 0.560 |
Why?
| | Fatty Liver | 3 | 2017 | 253 | 0.560 |
Why?
| | Immunosenescence | 2 | 2017 | 5 | 0.550 |
Why?
| | Epigenesis, Genetic | 4 | 2022 | 679 | 0.550 |
Why?
| | Pepsin A | 3 | 2014 | 18 | 0.550 |
Why?
| | Flow Cytometry | 6 | 2018 | 1162 | 0.540 |
Why?
| | Cell Proliferation | 1 | 2025 | 2507 | 0.540 |
Why?
| | Pseudomonas aeruginosa | 5 | 2014 | 395 | 0.540 |
Why?
| | Immunity | 3 | 2025 | 140 | 0.540 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2018 | 59 | 0.540 |
Why?
| | Aged | 25 | 2025 | 26153 | 0.520 |
Why?
| | Chemokine CCL2 | 1 | 2017 | 112 | 0.510 |
Why?
| | Histone Deacetylase 1 | 1 | 2016 | 23 | 0.490 |
Why?
| | Chemokine CXCL1 | 3 | 2025 | 76 | 0.490 |
Why?
| | Sepsis | 5 | 2023 | 664 | 0.490 |
Why?
| | Middle Aged | 31 | 2025 | 36215 | 0.490 |
Why?
| | Kupffer Cells | 1 | 2016 | 52 | 0.480 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2023 | 652 | 0.480 |
Why?
| | Myosin-Light-Chain Kinase | 2 | 2014 | 19 | 0.480 |
Why?
| | Spleen | 5 | 2011 | 508 | 0.480 |
Why?
| | Pulmonary Edema | 1 | 2016 | 105 | 0.470 |
Why?
| | Inflammation Mediators | 6 | 2015 | 506 | 0.470 |
Why?
| | Tissue Donors | 3 | 2018 | 420 | 0.470 |
Why?
| | Length of Stay | 3 | 2019 | 1349 | 0.460 |
Why?
| | Microbiota | 1 | 2023 | 730 | 0.460 |
Why?
| | Granulocyte Colony-Stimulating Factor | 2 | 2013 | 90 | 0.460 |
Why?
| | Adaptive Immunity | 2 | 2016 | 167 | 0.450 |
Why?
| | Laparoscopy | 5 | 2014 | 481 | 0.450 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 264 | 0.450 |
Why?
| | Intestine, Small | 2 | 2016 | 167 | 0.450 |
Why?
| | Bradykinin B2 Receptor Antagonists | 1 | 2015 | 1 | 0.440 |
Why?
| | Adult | 33 | 2025 | 40777 | 0.440 |
Why?
| | Bradykinin | 1 | 2015 | 49 | 0.430 |
Why?
| | Models, Animal | 6 | 2019 | 393 | 0.430 |
Why?
| | Oxidative Stress | 6 | 2025 | 1356 | 0.430 |
Why?
| | Immunologic Memory | 1 | 2017 | 368 | 0.430 |
Why?
| | Extracellular Traps | 1 | 2015 | 52 | 0.430 |
Why?
| | Respiration | 1 | 2015 | 206 | 0.430 |
Why?
| | Dehydration | 1 | 2015 | 58 | 0.420 |
Why?
| | Primary Graft Dysfunction | 1 | 2014 | 33 | 0.420 |
Why?
| | Esophageal pH Monitoring | 1 | 2014 | 22 | 0.410 |
Why?
| | Lipopolysaccharides | 5 | 2012 | 858 | 0.410 |
Why?
| | Breath Tests | 3 | 2016 | 77 | 0.400 |
Why?
| | Histones | 2 | 2016 | 666 | 0.400 |
Why?
| | Alanine Transaminase | 5 | 2025 | 151 | 0.400 |
Why?
| | Monocytes | 1 | 2016 | 539 | 0.390 |
Why?
| | Apoptosis | 7 | 2025 | 2440 | 0.390 |
Why?
| | Congresses as Topic | 4 | 2020 | 223 | 0.380 |
Why?
| | Scleroderma, Systemic | 1 | 2014 | 123 | 0.380 |
Why?
| | Ileitis | 1 | 2013 | 33 | 0.380 |
Why?
| | Dendritic Cells | 3 | 2016 | 499 | 0.380 |
Why?
| | Solvents | 1 | 2013 | 112 | 0.370 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2013 | 114 | 0.370 |
Why?
| | Research Personnel | 1 | 2014 | 184 | 0.370 |
Why?
| | Permeability | 3 | 2022 | 169 | 0.370 |
Why?
| | Graft Rejection | 2 | 2013 | 521 | 0.370 |
Why?
| | Career Choice | 1 | 2014 | 234 | 0.360 |
Why?
| | Mentors | 1 | 2014 | 217 | 0.360 |
Why?
| | Leukocyte Count | 5 | 2013 | 316 | 0.360 |
Why?
| | Intestinal Diseases | 1 | 2012 | 43 | 0.360 |
Why?
| | Staphylococcal Infections | 2 | 2013 | 391 | 0.360 |
Why?
| | rac GTP-Binding Proteins | 1 | 2012 | 35 | 0.360 |
Why?
| | Phagosomes | 1 | 2012 | 40 | 0.350 |
Why?
| | Fundoplication | 1 | 2012 | 52 | 0.350 |
Why?
| | Injury Severity Score | 5 | 2017 | 599 | 0.350 |
Why?
| | Receptors, IgG | 1 | 2012 | 77 | 0.350 |
Why?
| | Antibodies | 2 | 2013 | 397 | 0.340 |
Why?
| | Ischemia | 1 | 2015 | 422 | 0.340 |
Why?
| | Toll-Like Receptor 4 | 2 | 2010 | 276 | 0.340 |
Why?
| | Risk Factors | 12 | 2025 | 10885 | 0.330 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 9 | 2018 | 848 | 0.330 |
Why?
| | Ligands | 2 | 2023 | 665 | 0.330 |
Why?
| | Immunologic Factors | 2 | 2016 | 260 | 0.330 |
Why?
| | Logistic Models | 6 | 2019 | 2134 | 0.330 |
Why?
| | Prospective Studies | 9 | 2021 | 8057 | 0.320 |
Why?
| | Aspartate Aminotransferases | 3 | 2025 | 85 | 0.320 |
Why?
| | Down-Regulation | 1 | 2013 | 618 | 0.320 |
Why?
| | Cell Separation | 1 | 2011 | 305 | 0.320 |
Why?
| | Mice, Knockout | 7 | 2013 | 3124 | 0.310 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2010 | 132 | 0.310 |
Why?
| | Respiratory Function Tests | 3 | 2025 | 544 | 0.310 |
Why?
| | Cause of Death | 3 | 2019 | 470 | 0.310 |
Why?
| | Environmental Pollutants | 1 | 2011 | 139 | 0.300 |
Why?
| | Actins | 1 | 2012 | 425 | 0.300 |
Why?
| | Protein Precursors | 2 | 2025 | 136 | 0.300 |
Why?
| | Toll-Like Receptor 2 | 1 | 2010 | 125 | 0.300 |
Why?
| | Ileum | 2 | 2024 | 112 | 0.290 |
Why?
| | Immune Tolerance | 1 | 2012 | 385 | 0.290 |
Why?
| | Interleukin-12 | 2 | 2013 | 115 | 0.290 |
Why?
| | Receptors, Interleukin-8B | 2 | 2010 | 29 | 0.290 |
Why?
| | Illinois | 4 | 2017 | 49 | 0.280 |
Why?
| | Occludin | 2 | 2021 | 12 | 0.280 |
Why?
| | Smoking | 2 | 2013 | 1472 | 0.270 |
Why?
| | Cathelicidins | 2 | 2025 | 40 | 0.260 |
Why?
| | Time Factors | 9 | 2019 | 7123 | 0.260 |
Why?
| | Gastroenteritis | 1 | 2008 | 63 | 0.260 |
Why?
| | Plethysmography | 2 | 2019 | 104 | 0.260 |
Why?
| | Bronchoscopy | 3 | 2013 | 227 | 0.250 |
Why?
| | Peroxidase | 3 | 2016 | 168 | 0.250 |
Why?
| | Respiration, Artificial | 1 | 2012 | 713 | 0.250 |
Why?
| | Young Adult | 9 | 2025 | 14218 | 0.240 |
Why?
| | Microglia | 2 | 2026 | 270 | 0.240 |
Why?
| | Peptides | 1 | 2012 | 998 | 0.240 |
Why?
| | Bacteria | 3 | 2023 | 765 | 0.240 |
Why?
| | Statistics, Nonparametric | 5 | 2013 | 428 | 0.230 |
Why?
| | Trachea | 1 | 2008 | 258 | 0.230 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2025 | 72 | 0.230 |
Why?
| | Cholera Toxin | 1 | 2025 | 29 | 0.220 |
Why?
| | Laparotomy | 1 | 2025 | 113 | 0.220 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2025 | 68 | 0.220 |
Why?
| | Skin Ulcer | 2 | 2015 | 15 | 0.220 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2025 | 122 | 0.220 |
Why?
| | Neurofilament Proteins | 1 | 2025 | 79 | 0.220 |
Why?
| | Bacteroidetes | 1 | 2024 | 21 | 0.220 |
Why?
| | Haptoglobins | 1 | 2025 | 71 | 0.210 |
Why?
| | Mitochondria, Liver | 1 | 2025 | 70 | 0.210 |
Why?
| | Fecal Microbiota Transplantation | 1 | 2024 | 27 | 0.210 |
Why?
| | Exhalation | 2 | 2016 | 29 | 0.210 |
Why?
| | Survival Analysis | 3 | 2019 | 1374 | 0.210 |
Why?
| | Burn Units | 2 | 2022 | 41 | 0.200 |
Why?
| | Retrospective Studies | 10 | 2023 | 17291 | 0.200 |
Why?
| | ROC Curve | 5 | 2018 | 617 | 0.200 |
Why?
| | Toxoplasmosis | 1 | 2024 | 43 | 0.200 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2025 | 166 | 0.200 |
Why?
| | Toxoplasma | 1 | 2024 | 49 | 0.200 |
Why?
| | Fatty Acids, Volatile | 1 | 2024 | 60 | 0.200 |
Why?
| | Hepatocytes | 1 | 2025 | 224 | 0.200 |
Why?
| | Multivariate Analysis | 3 | 2023 | 1547 | 0.200 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2025 | 231 | 0.200 |
Why?
| | Hospital Mortality | 2 | 2019 | 1038 | 0.200 |
Why?
| | Aged, 80 and over | 5 | 2017 | 8333 | 0.200 |
Why?
| | Homeostasis | 2 | 2020 | 642 | 0.200 |
Why?
| | Cohort Studies | 9 | 2019 | 6013 | 0.190 |
Why?
| | Hawaii | 1 | 2023 | 37 | 0.190 |
Why?
| | Zonula Occludens-1 Protein | 2 | 2013 | 17 | 0.190 |
Why?
| | alpha-Defensins | 1 | 2022 | 11 | 0.190 |
Why?
| | Phenotype | 4 | 2020 | 3155 | 0.190 |
Why?
| | Whole-Body Irradiation | 2 | 2013 | 74 | 0.190 |
Why?
| | Body Surface Area | 1 | 2022 | 34 | 0.180 |
Why?
| | Mitochondrial Proteins | 1 | 2025 | 263 | 0.180 |
Why?
| | Caspases | 1 | 2023 | 233 | 0.180 |
Why?
| | Veterans Health | 1 | 2024 | 190 | 0.180 |
Why?
| | Sex Characteristics | 3 | 2016 | 782 | 0.180 |
Why?
| | Fluorescent Antibody Technique | 3 | 2014 | 365 | 0.180 |
Why?
| | Interleukin-1beta | 3 | 2020 | 389 | 0.170 |
Why?
| | Neurodegenerative Diseases | 1 | 2023 | 142 | 0.170 |
Why?
| | Veterans | 2 | 2024 | 1635 | 0.170 |
Why?
| | NF-kappa B | 1 | 2025 | 666 | 0.170 |
Why?
| | Critical Illness | 2 | 2018 | 900 | 0.170 |
Why?
| | Malondialdehyde | 1 | 2021 | 30 | 0.170 |
Why?
| | Interleukins | 2 | 2014 | 248 | 0.170 |
Why?
| | Injections, Intraperitoneal | 2 | 2013 | 116 | 0.170 |
Why?
| | Phosphorylation | 3 | 2016 | 1707 | 0.170 |
Why?
| | Analysis of Variance | 3 | 2014 | 1300 | 0.160 |
Why?
| | Lipid Peroxidation | 1 | 2021 | 167 | 0.160 |
Why?
| | Frailty | 1 | 2024 | 205 | 0.160 |
Why?
| | Hippocampus | 2 | 2025 | 971 | 0.160 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2023 | 248 | 0.160 |
Why?
| | Caspase 3 | 3 | 2023 | 242 | 0.160 |
Why?
| | Streptococcus pneumoniae | 1 | 2022 | 184 | 0.160 |
Why?
| | Boston | 1 | 2020 | 93 | 0.160 |
Why?
| | Organ Specificity | 1 | 2020 | 309 | 0.150 |
Why?
| | Resistin | 1 | 2019 | 12 | 0.150 |
Why?
| | Gastric Inhibitory Polypeptide | 1 | 2019 | 13 | 0.150 |
Why?
| | Ghrelin | 1 | 2019 | 42 | 0.150 |
Why?
| | Cells, Cultured | 7 | 2016 | 4148 | 0.150 |
Why?
| | Air Pollutants | 1 | 2024 | 405 | 0.150 |
Why?
| | Metformin | 1 | 2023 | 329 | 0.150 |
Why?
| | Mannose-Binding Lectins | 1 | 2019 | 10 | 0.150 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2019 | 85 | 0.150 |
Why?
| | Fires | 1 | 2020 | 77 | 0.150 |
Why?
| | Natural Killer T-Cells | 2 | 2010 | 71 | 0.150 |
Why?
| | Lectins, C-Type | 1 | 2019 | 59 | 0.150 |
Why?
| | Glutathione | 1 | 2021 | 370 | 0.150 |
Why?
| | Predictive Value of Tests | 3 | 2019 | 2121 | 0.140 |
Why?
| | Cell Count | 2 | 2016 | 319 | 0.140 |
Why?
| | Life Style | 2 | 2014 | 485 | 0.140 |
Why?
| | Risk Assessment | 5 | 2019 | 3747 | 0.140 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2010 | 155 | 0.140 |
Why?
| | Multiple Organ Failure | 2 | 2017 | 120 | 0.140 |
Why?
| | Nanoparticles | 1 | 2025 | 517 | 0.140 |
Why?
| | In Situ Nick-End Labeling | 1 | 2018 | 119 | 0.140 |
Why?
| | Administration, Oral | 2 | 2013 | 866 | 0.140 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2019 | 149 | 0.140 |
Why?
| | Leptin | 1 | 2019 | 248 | 0.130 |
Why?
| | Prognosis | 3 | 2018 | 4316 | 0.130 |
Why?
| | Linear Models | 2 | 2017 | 845 | 0.130 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 977 | 0.130 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 467 | 0.130 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2020 | 507 | 0.130 |
Why?
| | Toll-Like Receptors | 2 | 2009 | 193 | 0.130 |
Why?
| | Mental Health | 1 | 2024 | 793 | 0.130 |
Why?
| | Receptors, Cell Surface | 1 | 2019 | 372 | 0.120 |
Why?
| | Tobacco Use | 1 | 2017 | 62 | 0.120 |
Why?
| | Reproducibility of Results | 2 | 2019 | 3413 | 0.120 |
Why?
| | Transcriptome | 1 | 2023 | 1038 | 0.120 |
Why?
| | Needs Assessment | 1 | 2019 | 402 | 0.120 |
Why?
| | Diet | 2 | 2014 | 1277 | 0.120 |
Why?
| | Intensive Care Units | 4 | 2019 | 924 | 0.120 |
Why?
| | Follow-Up Studies | 2 | 2018 | 5423 | 0.120 |
Why?
| | United States | 10 | 2024 | 16098 | 0.120 |
Why?
| | Monocyte Chemoattractant Proteins | 1 | 2015 | 7 | 0.120 |
Why?
| | Phylogeny | 1 | 2020 | 917 | 0.110 |
Why?
| | Ovariectomy | 1 | 2016 | 166 | 0.110 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2010 | 2028 | 0.110 |
Why?
| | Chemokine CXCL2 | 1 | 2015 | 41 | 0.110 |
Why?
| | Acetylation | 1 | 2016 | 259 | 0.110 |
Why?
| | Incidence | 3 | 2019 | 2923 | 0.110 |
Why?
| | Regression Analysis | 3 | 2013 | 1001 | 0.110 |
Why?
| | Apicomplexa | 1 | 2015 | 3 | 0.110 |
Why?
| | Polymerase Chain Reaction | 1 | 2018 | 1041 | 0.110 |
Why?
| | Imidazoles | 1 | 2016 | 247 | 0.110 |
Why?
| | Brain | 2 | 2026 | 2947 | 0.110 |
Why?
| | Enzyme Inhibitors | 2 | 2016 | 820 | 0.110 |
Why?
| | Negative-Pressure Wound Therapy | 1 | 2015 | 29 | 0.110 |
Why?
| | Hematocrit | 1 | 2015 | 108 | 0.110 |
Why?
| | Wasting Syndrome | 1 | 2014 | 12 | 0.110 |
Why?
| | Killer Cells, Natural | 2 | 2008 | 480 | 0.110 |
Why?
| | Gene Expression | 2 | 2018 | 1476 | 0.110 |
Why?
| | Electric Stimulation Therapy | 1 | 2015 | 62 | 0.100 |
Why?
| | Radiation Dosage | 1 | 2016 | 193 | 0.100 |
Why?
| | Alcohol-Related Disorders | 1 | 2015 | 121 | 0.100 |
Why?
| | Respiratory Tract Diseases | 1 | 2016 | 175 | 0.100 |
Why?
| | Systemic Inflammatory Response Syndrome | 2 | 2014 | 95 | 0.100 |
Why?
| | Cognition | 1 | 2023 | 1266 | 0.100 |
Why?
| | Fast Foods | 1 | 2014 | 21 | 0.100 |
Why?
| | Interleukin-23 | 1 | 2014 | 16 | 0.100 |
Why?
| | Insulin | 2 | 2019 | 2512 | 0.100 |
Why?
| | Chi-Square Distribution | 2 | 2013 | 527 | 0.100 |
Why?
| | Leukocyte Disorders | 1 | 2014 | 9 | 0.100 |
Why?
| | Fungi | 1 | 2015 | 121 | 0.100 |
Why?
| | Health | 1 | 2014 | 82 | 0.100 |
Why?
| | Sex Factors | 4 | 2019 | 2105 | 0.100 |
Why?
| | Caspase 8 | 1 | 2013 | 47 | 0.100 |
Why?
| | Immune System Diseases | 1 | 2014 | 37 | 0.100 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2014 | 60 | 0.100 |
Why?
| | Lymphocyte Subsets | 1 | 2013 | 77 | 0.100 |
Why?
| | Faculty | 1 | 2014 | 147 | 0.100 |
Why?
| | Lung Injury | 1 | 2016 | 244 | 0.100 |
Why?
| | Myosin Light Chains | 1 | 2013 | 28 | 0.100 |
Why?
| | Th17 Cells | 1 | 2014 | 101 | 0.100 |
Why?
| | Viruses | 1 | 2015 | 165 | 0.090 |
Why?
| | Creatinine | 1 | 2015 | 515 | 0.090 |
Why?
| | Immunoassay | 1 | 2013 | 109 | 0.090 |
Why?
| | Employment | 1 | 2014 | 184 | 0.090 |
Why?
| | Bile Acids and Salts | 1 | 2014 | 163 | 0.090 |
Why?
| | Adipose Tissue | 2 | 2015 | 645 | 0.090 |
Why?
| | Calcitonin | 1 | 2012 | 27 | 0.090 |
Why?
| | Bacterial Load | 1 | 2012 | 67 | 0.090 |
Why?
| | Vinculin | 1 | 2012 | 10 | 0.090 |
Why?
| | Anti-Infective Agents | 1 | 2015 | 232 | 0.090 |
Why?
| | Paxillin | 1 | 2012 | 11 | 0.090 |
Why?
| | Syndrome | 1 | 2013 | 381 | 0.090 |
Why?
| | Social Class | 1 | 2014 | 264 | 0.090 |
Why?
| | Pyridines | 1 | 2016 | 609 | 0.090 |
Why?
| | Receptors, Interleukin-4 | 1 | 2011 | 16 | 0.090 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2013 | 253 | 0.090 |
Why?
| | Decidua | 1 | 1992 | 22 | 0.090 |
Why?
| | Receptors, Interleukin-2 | 1 | 1992 | 64 | 0.090 |
Why?
| | Chorionic Villi | 1 | 1992 | 25 | 0.090 |
Why?
| | Focal Adhesions | 1 | 2012 | 47 | 0.090 |
Why?
| | Cell Differentiation | 2 | 2016 | 2046 | 0.090 |
Why?
| | Hypertension, Pulmonary | 1 | 2023 | 1957 | 0.090 |
Why?
| | Ubiquitin | 1 | 2012 | 83 | 0.090 |
Why?
| | Research Support as Topic | 1 | 2012 | 80 | 0.090 |
Why?
| | rho GTP-Binding Proteins | 1 | 2012 | 56 | 0.090 |
Why?
| | Chemokine CXCL12 | 1 | 2012 | 86 | 0.090 |
Why?
| | Pregnancy | 2 | 2023 | 7202 | 0.090 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2011 | 162 | 0.090 |
Why?
| | Polymerization | 1 | 2012 | 127 | 0.080 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2012 | 267 | 0.080 |
Why?
| | Vehicle Emissions | 1 | 2011 | 57 | 0.080 |
Why?
| | Confidence Intervals | 1 | 2012 | 330 | 0.080 |
Why?
| | Phagocytes | 2 | 2009 | 80 | 0.080 |
Why?
| | Nitric Oxide | 1 | 2016 | 892 | 0.080 |
Why?
| | Pulmonary Alveoli | 1 | 2013 | 385 | 0.080 |
Why?
| | Blood Glucose | 2 | 2019 | 2341 | 0.080 |
Why?
| | Immunohistochemistry | 1 | 2015 | 1716 | 0.080 |
Why?
| | Cytoskeleton | 1 | 2012 | 192 | 0.080 |
Why?
| | Edema | 1 | 2011 | 125 | 0.080 |
Why?
| | Tissue Engineering | 1 | 2015 | 439 | 0.080 |
Why?
| | Ozone | 1 | 2011 | 115 | 0.080 |
Why?
| | Body Composition | 1 | 2014 | 693 | 0.080 |
Why?
| | Bone Marrow Cells | 1 | 2011 | 321 | 0.080 |
Why?
| | Writing | 1 | 2012 | 101 | 0.080 |
Why?
| | Specimen Handling | 1 | 2012 | 182 | 0.080 |
Why?
| | Dermatitis | 1 | 2010 | 20 | 0.080 |
Why?
| | Equipment Design | 1 | 2012 | 525 | 0.080 |
Why?
| | DNA | 2 | 2015 | 1435 | 0.080 |
Why?
| | Bacteremia | 1 | 2012 | 222 | 0.080 |
Why?
| | Heart Failure | 1 | 2023 | 2326 | 0.080 |
Why?
| | Adiposity | 1 | 2014 | 532 | 0.080 |
Why?
| | Respiration Disorders | 1 | 2010 | 78 | 0.070 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2011 | 237 | 0.070 |
Why?
| | Trophoblasts | 1 | 1992 | 218 | 0.070 |
Why?
| | Adolescent | 5 | 2017 | 22529 | 0.070 |
Why?
| | Interleukin-18 | 1 | 2010 | 234 | 0.070 |
Why?
| | Cystic Fibrosis | 1 | 2019 | 1161 | 0.070 |
Why?
| | Odds Ratio | 1 | 2012 | 1082 | 0.070 |
Why?
| | Severity of Illness Index | 2 | 2019 | 2930 | 0.070 |
Why?
| | Histiocytes | 1 | 2008 | 7 | 0.070 |
Why?
| | Escherichia coli K12 | 1 | 2008 | 7 | 0.070 |
Why?
| | Mass Screening | 2 | 2015 | 1360 | 0.070 |
Why?
| | Membrane Fluidity | 1 | 2008 | 8 | 0.070 |
Why?
| | bcl-X Protein | 2 | 2023 | 45 | 0.070 |
Why?
| | Kaplan-Meier Estimate | 1 | 2011 | 969 | 0.070 |
Why?
| | Acute Lung Injury | 1 | 2012 | 305 | 0.070 |
Why?
| | Hypersensitivity, Delayed | 1 | 2008 | 29 | 0.070 |
Why?
| | Interleukin-2 | 1 | 2009 | 440 | 0.070 |
Why?
| | Membrane Microdomains | 1 | 2008 | 34 | 0.070 |
Why?
| | Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2008 | 17 | 0.070 |
Why?
| | Feeding Behavior | 1 | 2014 | 690 | 0.070 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2008 | 86 | 0.070 |
Why?
| | Opportunistic Infections | 1 | 2008 | 47 | 0.070 |
Why?
| | Manometry | 3 | 2013 | 98 | 0.070 |
Why?
| | Shock | 1 | 2009 | 110 | 0.070 |
Why?
| | Comorbidity | 3 | 2019 | 1661 | 0.070 |
Why?
| | Protein Kinase Inhibitors | 1 | 2014 | 981 | 0.070 |
Why?
| | Asthma | 2 | 2016 | 1797 | 0.070 |
Why?
| | Cell Survival | 2 | 2025 | 1100 | 0.070 |
Why?
| | Capillary Permeability | 1 | 2008 | 132 | 0.060 |
Why?
| | Testis | 1 | 2008 | 162 | 0.060 |
Why?
| | Protein Kinases | 1 | 2009 | 312 | 0.060 |
Why?
| | Staphylococcus aureus | 1 | 2011 | 451 | 0.060 |
Why?
| | Intubation, Gastrointestinal | 1 | 2008 | 81 | 0.060 |
Why?
| | Pediatric Obesity | 1 | 2014 | 638 | 0.060 |
Why?
| | Survival Rate | 1 | 2012 | 2090 | 0.060 |
Why?
| | Mast Cells | 1 | 2008 | 147 | 0.060 |
Why?
| | Neovascularization, Physiologic | 1 | 2008 | 192 | 0.060 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2013 | 531 | 0.060 |
Why?
| | Reproduction | 1 | 2008 | 208 | 0.060 |
Why?
| | In Vitro Techniques | 1 | 2008 | 1048 | 0.060 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2008 | 199 | 0.060 |
Why?
| | Gonadal Steroid Hormones | 1 | 2008 | 143 | 0.060 |
Why?
| | Interleukin-1 | 1 | 2010 | 961 | 0.060 |
Why?
| | Angiogenesis Inhibitors | 1 | 2008 | 238 | 0.060 |
Why?
| | Cell Line | 1 | 2012 | 2823 | 0.060 |
Why?
| | Interferon-gamma | 1 | 2009 | 784 | 0.060 |
Why?
| | Keratin-18 | 1 | 2025 | 12 | 0.060 |
Why?
| | Cell Communication | 1 | 2008 | 328 | 0.060 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2013 | 692 | 0.060 |
Why?
| | Eosinophils | 1 | 2008 | 316 | 0.060 |
Why?
| | Research Design | 1 | 2012 | 1137 | 0.060 |
Why?
| | Reference Values | 2 | 2019 | 798 | 0.060 |
Why?
| | Treatment Outcome | 2 | 2012 | 11772 | 0.060 |
Why?
| | Sensitivity and Specificity | 3 | 2018 | 1997 | 0.060 |
Why?
| | Serum Amyloid A Protein | 1 | 2025 | 32 | 0.060 |
Why?
| | Kynurenine | 1 | 2025 | 114 | 0.050 |
Why?
| | Polymorphism, Genetic | 1 | 2008 | 614 | 0.050 |
Why?
| | Acute Disease | 1 | 2008 | 1036 | 0.050 |
Why?
| | Tryptophan | 1 | 2025 | 182 | 0.050 |
Why?
| | Barrett Esophagus | 3 | 2012 | 169 | 0.050 |
Why?
| | Lomustine | 1 | 2024 | 17 | 0.050 |
Why?
| | Anti-Inflammatory Agents | 1 | 2008 | 477 | 0.050 |
Why?
| | Antioxidants | 1 | 2008 | 550 | 0.050 |
Why?
| | Antibodies, Protozoan | 1 | 2024 | 41 | 0.050 |
Why?
| | Neoplasms | 2 | 2016 | 2906 | 0.050 |
Why?
| | Gene Silencing | 1 | 2025 | 202 | 0.050 |
Why?
| | Metals, Heavy | 1 | 2024 | 31 | 0.050 |
Why?
| | Inflammasomes | 1 | 2025 | 144 | 0.050 |
Why?
| | Hemorrhage | 1 | 2009 | 822 | 0.050 |
Why?
| | Pesticides | 1 | 2024 | 59 | 0.050 |
Why?
| | Anti-Bacterial Agents | 1 | 2014 | 1923 | 0.050 |
Why?
| | Case-Control Studies | 4 | 2015 | 3623 | 0.050 |
Why?
| | Caspase 9 | 1 | 2023 | 55 | 0.050 |
Why?
| | Europe | 2 | 2014 | 418 | 0.050 |
Why?
| | STAT3 Transcription Factor | 1 | 2025 | 206 | 0.050 |
Why?
| | Surveys and Questionnaires | 4 | 2019 | 6066 | 0.050 |
Why?
| | Prednisone | 1 | 2024 | 224 | 0.050 |
Why?
| | Immunoglobulin M | 1 | 2024 | 265 | 0.050 |
Why?
| | Exercise | 1 | 2014 | 2198 | 0.050 |
Why?
| | Lymphocytes | 1 | 1984 | 376 | 0.040 |
Why?
| | Virulence | 1 | 2023 | 278 | 0.040 |
Why?
| | Endothelial Cells | 1 | 2008 | 874 | 0.040 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2023 | 192 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2025 | 611 | 0.040 |
Why?
| | DNA Repair | 1 | 1984 | 254 | 0.040 |
Why?
| | Energy Metabolism | 1 | 2008 | 935 | 0.040 |
Why?
| | Liver Cirrhosis | 1 | 2023 | 287 | 0.040 |
Why?
| | Hernia, Hiatal | 2 | 2012 | 39 | 0.040 |
Why?
| | Blood Alcohol Content | 1 | 2021 | 6 | 0.040 |
Why?
| | Colorado | 2 | 2024 | 4553 | 0.040 |
Why?
| | Ventricular Remodeling | 1 | 2023 | 278 | 0.040 |
Why?
| | Ventricular Function, Right | 1 | 2023 | 297 | 0.040 |
Why?
| | Air Pollution | 1 | 2024 | 314 | 0.040 |
Why?
| | Immunoglobulin G | 1 | 2024 | 892 | 0.040 |
Why?
| | MicroRNAs | 1 | 2025 | 686 | 0.040 |
Why?
| | Firefighters | 1 | 2020 | 47 | 0.040 |
Why?
| | Environmental Exposure | 1 | 2024 | 578 | 0.040 |
Why?
| | United States Department of Veterans Affairs | 1 | 2024 | 778 | 0.040 |
Why?
| | Chronic Disease | 2 | 2015 | 1808 | 0.040 |
Why?
| | Patient-Centered Care | 1 | 2024 | 547 | 0.040 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2013 | 552 | 0.030 |
Why?
| | Patient Care Team | 1 | 2024 | 696 | 0.030 |
Why?
| | Half-Life | 1 | 2018 | 155 | 0.030 |
Why?
| | Reference Standards | 1 | 2018 | 177 | 0.030 |
Why?
| | Age of Onset | 1 | 2019 | 555 | 0.030 |
Why?
| | California | 1 | 2019 | 471 | 0.030 |
Why?
| | National Heart, Lung, and Blood Institute (U.S.) | 1 | 2017 | 103 | 0.030 |
Why?
| | Disease Progression | 2 | 2015 | 2864 | 0.030 |
Why?
| | Forkhead Box Protein O3 | 1 | 2016 | 18 | 0.030 |
Why?
| | Shock, Septic | 1 | 2019 | 227 | 0.030 |
Why?
| | International Classification of Diseases | 1 | 2017 | 150 | 0.030 |
Why?
| | Dried Blood Spot Testing | 1 | 2017 | 126 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2023 | 1767 | 0.030 |
Why?
| | Academic Medical Centers | 1 | 2019 | 554 | 0.030 |
Why?
| | Bronchoalveolar Lavage | 1 | 2015 | 89 | 0.030 |
Why?
| | Propensity Score | 1 | 2017 | 377 | 0.030 |
Why?
| | Rats | 3 | 2014 | 5584 | 0.030 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2016 | 364 | 0.030 |
Why?
| | Endocrine System | 1 | 2014 | 22 | 0.030 |
Why?
| | Self Report | 1 | 2019 | 870 | 0.030 |
Why?
| | Administration, Topical | 1 | 2015 | 153 | 0.030 |
Why?
| | Psoriasis | 1 | 2015 | 115 | 0.030 |
Why?
| | Hemostasis | 1 | 2014 | 98 | 0.030 |
Why?
| | Anthropometry | 1 | 2014 | 206 | 0.030 |
Why?
| | Prevalence | 2 | 2011 | 2865 | 0.020 |
Why?
| | Principal Component Analysis | 1 | 2014 | 193 | 0.020 |
Why?
| | Pneumonia, Aspiration | 1 | 2013 | 16 | 0.020 |
Why?
| | C-Reactive Protein | 1 | 2016 | 422 | 0.020 |
Why?
| | Canada | 1 | 2015 | 431 | 0.020 |
Why?
| | Culture | 1 | 2014 | 124 | 0.020 |
Why?
| | Chemokine CCL5 | 1 | 2013 | 40 | 0.020 |
Why?
| | Virus Diseases | 1 | 2015 | 216 | 0.020 |
Why?
| | Forecasting | 1 | 2015 | 390 | 0.020 |
Why?
| | Area Under Curve | 1 | 2014 | 331 | 0.020 |
Why?
| | Critical Care | 1 | 2019 | 702 | 0.020 |
Why?
| | Gene Expression Regulation | 2 | 2013 | 2597 | 0.020 |
Why?
| | Acute-Phase Proteins | 1 | 2012 | 66 | 0.020 |
Why?
| | Health Surveys | 1 | 2014 | 518 | 0.020 |
Why?
| | Disease Management | 1 | 2016 | 653 | 0.020 |
Why?
| | Calcitonin Gene-Related Peptide | 1 | 2012 | 40 | 0.020 |
Why?
| | Technetium Tc 99m Sulfur Colloid | 1 | 2012 | 6 | 0.020 |
Why?
| | Barium Sulfate | 1 | 2012 | 14 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2016 | 1508 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2024 | 5904 | 0.020 |
Why?
| | Societies, Medical | 1 | 2016 | 899 | 0.020 |
Why?
| | Fluorescence | 1 | 2012 | 159 | 0.020 |
Why?
| | Gastric Emptying | 1 | 2012 | 36 | 0.020 |
Why?
| | Metabolomics | 1 | 2017 | 732 | 0.020 |
Why?
| | Pregnancy Trimester, First | 1 | 1992 | 139 | 0.020 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 1992 | 132 | 0.020 |
Why?
| | Monitoring, Ambulatory | 1 | 2012 | 89 | 0.020 |
Why?
| | Radiopharmaceuticals | 1 | 2012 | 205 | 0.020 |
Why?
| | Esophagitis | 1 | 2011 | 67 | 0.020 |
Why?
| | Liver Transplantation | 1 | 2018 | 826 | 0.020 |
Why?
| | DNA Fragmentation | 1 | 2010 | 40 | 0.020 |
Why?
| | bcl-2-Associated X Protein | 1 | 2010 | 53 | 0.020 |
Why?
| | Drug Administration Routes | 1 | 2010 | 42 | 0.020 |
Why?
| | Pneumonia, Viral | 1 | 2015 | 389 | 0.020 |
Why?
| | Morbidity | 1 | 2011 | 322 | 0.020 |
Why?
| | Chromatography, Gel | 1 | 2009 | 130 | 0.020 |
Why?
| | Antigens, CD1d | 1 | 2009 | 69 | 0.020 |
Why?
| | Membrane Glycoproteins | 1 | 2012 | 499 | 0.020 |
Why?
| | Abortion, Induced | 1 | 1992 | 110 | 0.020 |
Why?
| | Radiography | 1 | 2012 | 852 | 0.020 |
Why?
| | Esophagus | 1 | 2011 | 262 | 0.020 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 919 | 0.020 |
Why?
| | Child, Preschool | 2 | 2014 | 11853 | 0.020 |
Why?
| | Cell Movement | 1 | 2013 | 959 | 0.020 |
Why?
| | Nursing Assessment | 1 | 2009 | 53 | 0.020 |
Why?
| | Reoperation | 1 | 2012 | 633 | 0.020 |
Why?
| | Contrast Media | 1 | 2012 | 497 | 0.020 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 1992 | 409 | 0.020 |
Why?
| | tert-Butyl Alcohol | 1 | 2008 | 1 | 0.020 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2009 | 177 | 0.020 |
Why?
| | Alcohol Dehydrogenase | 1 | 2008 | 16 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2010 | 782 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2012 | 728 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 1991 | 474 | 0.020 |
Why?
| | Oligopeptides | 1 | 2010 | 267 | 0.020 |
Why?
| | Antibodies, Neutralizing | 1 | 2010 | 340 | 0.020 |
Why?
| | Cell Hypoxia | 1 | 2008 | 247 | 0.020 |
Why?
| | Collagen | 1 | 2009 | 457 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 2010 | 1132 | 0.010 |
Why?
| | Risk-Taking | 1 | 2009 | 323 | 0.010 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2008 | 296 | 0.010 |
Why?
| | Body Mass Index | 1 | 2014 | 2445 | 0.010 |
Why?
| | Fibroblasts | 1 | 1991 | 1025 | 0.010 |
Why?
| | Cell Nucleus | 1 | 2008 | 588 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2010 | 2524 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2013 | 1996 | 0.010 |
Why?
| | Hydroxyurea | 1 | 1984 | 34 | 0.010 |
Why?
| | Child | 2 | 2014 | 22707 | 0.010 |
Why?
| | Testosterone | 1 | 2008 | 416 | 0.010 |
Why?
| | Pyrazoles | 1 | 2008 | 517 | 0.010 |
Why?
| | Quality of Life | 1 | 2015 | 3204 | 0.010 |
Why?
| | Ultraviolet Rays | 1 | 1984 | 384 | 0.010 |
Why?
| | Registries | 1 | 2008 | 2406 | 0.010 |
Why?
| | Bleomycin | 1 | 1991 | 255 | 0.000 |
Why?
| | Oxygen | 1 | 1991 | 978 | 0.000 |
Why?
| | RNA, Messenger | 1 | 1991 | 2803 | 0.000 |
Why?
|
|
Kovacs's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|